ArticleScientific reports2025

Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy.

Ruijing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.